InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Malin Life Sciences Holdings Ltd. Director active across 1 company, notably Poseida Therapeutics, Inc.. Cumulatively, 7 reports have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €7.8m. Activity tracked since 16 November 2021. The latest transaction was disclosed on 8 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Malin Life Sciences Holdings Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,835,673 sharesCOMMON STOCKSEC:0001104659-25-002540:0
2,150,000 shares@ US$3.5089.4% of flowCOMMON STOCKSEC:0001104659-22-088886:0
Canonical exit: 6 Nov 2022 (T+90)
1,828 shares@ US$6.901.3% of flowCOMMON STOCKSEC:0001104659-21-146952:0
Canonical exit: 6 Mar 2022 (T+90)
28,592 shares@ US$6.849419.8% of flowCOMMON STOCKSEC:0001104659-21-146000:0
Canonical exit: 28 Feb 2022 (T+90)
1,054 shares@ US$6.88820.7% of flowCOMMON STOCKSEC:0001104659-21-144590:0
Canonical exit: 22 Feb 2022 (T+90)
11,104 shares@ US$7.44338.3% of flowCOMMON STOCKSEC:0001104659-21-143142:0
Canonical exit: 17 Feb 2022 (T+90)
27,680 shares@ US$7.16719.9% of flowCOMMON STOCKSEC:0001104659-21-141457:0
Canonical exit: 14 Feb 2022 (T+90)
7 of 7 declarations
About Malin Life Sciences Holdings Ltd
Malin Life Sciences Holdings Ltd is a director at Poseida Therapeutics, Inc.
